These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24023334)

  • 21. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
    Ciledağ A; Kaya A; Yetkin O; Poyraz B; Savaş I; Numanoğlu N; Savaş H
    Tuberk Toraks; 2008; 56(4):390-5. PubMed ID: 19123074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling.
    Suzuki M; Wada H; Yoshino M; Tian L; Shigematsu H; Suzuki H; Alaa M; Tamura H; Fujiwara T; Nagato K; Motohashi S; Moriya Y; Hoshino H; Yoshida S; Shibuya K; Hiroshima K; Nakatani Y; Yoshino I
    Ann Surg Oncol; 2010 Mar; 17(3):878-88. PubMed ID: 19841986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group.
    Umemura S; Tsubouchi K; Yoshioka H; Hotta K; Takigawa N; Fujiwara K; Horita N; Segawa Y; Hamada N; Takata I; Yamane H; Kamei H; Kiura K; Tanimoto M
    Lung Cancer; 2012 Jul; 77(1):134-9. PubMed ID: 22487432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of epidermal growth factor receptor mutations and insulin-like growth factor 1 and its binding protein 3 in advanced non-squamous non-small cell lung cancer.
    Masago K; Fujita S; Togashi Y; Kim YH; Hatachi Y; Fukuhara A; Nagai H; Irisa K; Sakamori Y; Mio T; Mishima M
    Oncol Rep; 2011 Oct; 26(4):795-803. PubMed ID: 21805046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complex mutation patterns of epidermal growth factor receptor gene associated with variable responses to gefitinib treatment in patients with non-small cell lung cancer.
    Hsieh MH; Fang YF; Chang WC; Kuo HP; Lin SY; Liu HP; Liu CL; Chen HC; Ku YC; Chen YT; Chang YH; Chen YT; Hsi BL; Tsai SF; Huang SF
    Lung Cancer; 2006 Sep; 53(3):311-22. PubMed ID: 16870303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patients.
    Jantus-Lewintre E; Sirera R; Cabrera A; Blasco A; Caballero C; Iranzo V; Rosell R; Camps C
    Clin Lung Cancer; 2011 Sep; 12(5):320-7. PubMed ID: 21729651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.
    Cox G; Jones JL; O'Byrne KJ
    Clin Cancer Res; 2000 Jun; 6(6):2349-55. PubMed ID: 10873086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
    Volante M; Saviozzi S; Rapa I; Ceppi P; Cappia S; Calogero R; Novello S; Borasio P; Papotti M; Scagliotti GV
    Cancer; 2007 Sep; 110(6):1321-8. PubMed ID: 17647268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aryl hydrocarbon receptor in association with RelA modulates IL-6 expression in non-smoking lung cancer.
    Chen PH; Chang H; Chang JT; Lin P
    Oncogene; 2012 May; 31(20):2555-65. PubMed ID: 21996739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial-mesenchymal transition in non-small cell lung cancer cells.
    Li CH; Liu CW; Tsai CH; Peng YJ; Yang YH; Liao PL; Lee CC; Cheng YW; Kang JJ
    Arch Toxicol; 2017 May; 91(5):2165-2178. PubMed ID: 27752740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of aryl hydrocarbon receptor and cytochrome P4501B1 expressions in human non-small cell lung cancers.
    Lin P; Chang H; Ho WL; Wu MH; Su JM
    Lung Cancer; 2003 Dec; 42(3):255-61. PubMed ID: 14644512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased cytochrome P450 and aryl hydrocarbon receptor in bronchial epithelium of heavy smokers with non-small cell lung carcinoma carries a poor prognosis.
    Oyama T; Sugio K; Uramoto H; Iwata T; Onitsuka T; Isse T; Nozoe T; Kagawa N; Yasumoto K; Kawamoto T
    Front Biosci; 2007 May; 12():4497-503. PubMed ID: 17485391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inhibition of lung cancer cell migration by AhR-regulated autophagy.
    Tsai CH; Li CH; Cheng YW; Lee CC; Liao PL; Lin CH; Huang SH; Kang JJ
    Sci Rep; 2017 Feb; 7():41927. PubMed ID: 28195146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of aryl hydrocarbon receptor in human lung carcinomas.
    Lin P; Chang H; Tsai WT; Wu MH; Liao YS; Chen JT; Su JM
    Toxicol Pathol; 2003; 31(1):22-30. PubMed ID: 12597446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear trafficking of EGFR by Vps34 represses Arf expression to promote lung tumor cell survival.
    Dayde D; Guerard M; Perron P; Hatat AS; Barrial C; Eymin B; Gazzeri S
    Oncogene; 2016 Jul; 35(30):3986-94. PubMed ID: 26686095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation and overexpression of the aryl hydrocarbon receptor contribute to cutaneous squamous cell carcinomas: an immunohistochemical study.
    Pan ZY; Chen J; Wu Q; Hu TT; Lu L; Ju Q
    Diagn Pathol; 2018 Aug; 13(1):59. PubMed ID: 30144817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer.
    Kim JS; Cho MS; Nam JH; Kim HJ; Choi KW; Ryu JS
    PLoS One; 2017; 12(5):e0177015. PubMed ID: 28486527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients.
    Deuster E; Mayr D; Hester A; Kolben T; Zeder-Göß C; Burges A; Mahner S; Jeschke U; Trillsch F; Czogalla B
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor β and epidermal growth factor receptor as early-stage prognostic biomarkers of non-small cell lung cancer.
    Mauro LV; Dalurzo M; Carlini MJ; Smith D; Nuñez M; Simian M; Lastiri J; Vasallo B; Bal de Kier Joffé E; Pallotta MG; Puricelli L
    Oncol Rep; 2010 Nov; 24(5):1331-8. PubMed ID: 20878128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear Accumulation of Heat-shock Protein 90 Is Associated with Poor Survival and Metastasis in Patients with Non-small Cell Lung Cancer.
    Su JM; Hsu YY; Lin P; Chang H
    Anticancer Res; 2016 May; 36(5):2197-203. PubMed ID: 27127123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.